Published in BMJ on April 09, 2014
A model to determine colorectal cancer risk using common genetic susceptibility loci. Gastroenterology (2015) 2.14
Colonoscopy Reduces Colorectal Cancer Incidence and Mortality in Patients With Non-Malignant Findings: A Meta-Analysis. Am J Gastroenterol (2016) 1.09
Incidence trends and age distribution of colorectal cancer by subsite in Guangzhou, 2000-2011. Chin J Cancer (2015) 1.08
Colorectal cancer. Nat Rev Dis Prim (2015) 1.07
Reducing inequities in colorectal cancer screening in North America. J Carcinog (2014) 1.00
Colorectal cancer prevention by an optimized colonoscopy protocol in routine practice. Int J Cancer (2014) 0.97
The State of Cancer Care in America, 2016: A Report by the American Society of Clinical Oncology. J Oncol Pract (2016) 0.91
Impact of Screening Program on Incidence of Colorectal Cancer: A Cohort Study in Italy. Am J Gastroenterol (2015) 0.89
The value of models in informing resource allocation in colorectal cancer screening: the case of the Netherlands. Gut (2015) 0.87
Effectiveness of Screening Colonoscopy to Prevent Colorectal Cancer Among Medicare Beneficiaries Aged 70 to 79 Years: A Prospective Observational Study. Ann Intern Med (2016) 0.87
Primary care characteristics and stage of cancer at diagnosis using data from the national cancer registration service, quality outcomes framework and general practice information. BMC Cancer (2015) 0.86
Screening rates for colorectal cancer in Canada: a cross-sectional study. CMAJ Open (2015) 0.85
External Validation of the Endoscopic Features of Sessile Serrated Adenomas in Expert and Trainee Colonoscopists. Clin Endosc (2016) 0.85
Declining Bowel Cancer Incidence and Mortality in Germany. Dtsch Arztebl Int (2016) 0.83
Developments in Screening Tests and Strategies for Colorectal Cancer. Biomed Res Int (2015) 0.80
Prospective evaluation of 64 serum autoantibodies as biomarkers for early detection of colorectal cancer in a true screening setting. Oncotarget (2016) 0.80
hERG1 Potassium Channels: Novel Biomarkers in Human Solid Cancers. Biomed Res Int (2015) 0.80
Quantifying the utility of single nucleotide polymorphisms to guide colorectal cancer screening. Future Oncol (2016) 0.79
Expert opinions and scientific evidence for colonoscopy key performance indicators. Gut (2016) 0.77
Familial Risk and Heritability of Colorectal Cancer in the Nordic Twin Study of Cancer. Clin Gastroenterol Hepatol (2017) 0.76
Colorectal cancer screening: the time to act is now. BMC Med (2015) 0.76
Choosing the optimal method in programmatic colorectal cancer screening: current evidence and controversies. Therap Adv Gastroenterol (2015) 0.76
A meta-analysis of the effects of statin treatment on cardiovascular events and all-cause mortality in diabetic dialysis patients. Int J Clin Exp Med (2015) 0.76
Endoscopic mucosal resection of colorectal adenomas > 20 mm: Risk factors for recurrence. World J Gastrointest Endosc (2016) 0.76
Outreach and Inreach Organized Service Screening Programs for Colorectal Cancer. PLoS One (2016) 0.75
Screening for Bowel Cancer: Increasing Participation via Personal Invitation. Dtsch Arztebl Int (2017) 0.75
Epigenome-wide discovery and evaluation of leukocyte DNA methylation markers for the detection of colorectal cancer in a screening setting. Clin Epigenetics (2017) 0.75
Chemoprevention of colorectal cancer in individuals with previous colorectal neoplasia: systematic review and network meta-analysis. BMJ (2016) 0.75
Expected long-term impact of screening endoscopy on colorectal cancer incidence: a modelling study. Oncotarget (2016) 0.75
Diagnosis reliability of combined flexible sigmoidoscopy and fecal-immunochemical test in colorectal neoplasia screening. Onco Targets Ther (2016) 0.75
Colorectal Cancer Screening in Average Risk Populations: Evidence Summary. Can J Gastroenterol Hepatol (2016) 0.75
The risk of colorectal cancer is not increased after a diagnosis of urothelial cancer: a population-based study. Curr Oncol (2016) 0.75
Colonoscopy in Colorectal Cancer Screening: Current Aspects. Indian J Surg Oncol (2015) 0.75
Mortality From Malignant Melanoma in an Era of Nationwide Skin Cancer Screening. Dtsch Arztebl Int (2015) 0.75
Telephone Consultation-What Standards Should Apply? Dtsch Arztebl Int (2016) 0.75
Validation of a risk prediction score for proximal neoplasia in colorectal cancer screening: a prospective colonoscopy study. Sci Rep (2016) 0.75
Does a Pre-Training Program Influence Colonoscopy Proficiency during Fellowship? PLoS One (2016) 0.75
Spatial and temporal variations of screening for breast and colorectal cancer in the United States, 2008 to 2012. Medicine (Baltimore) (2016) 0.75
Survival of patients with symptom- and screening-detected colorectal cancer. Oncotarget (2016) 0.75
Individual- and neighborhood-level predictors of mortality in Florida colorectal cancer patients. PLoS One (2014) 0.75
More Is Not Always Better: A Randomized Trial Of Low Volume Oral Laxative, Enemas, And Combination Of Both Demonstrate That Enemas Alone Are Most Efficacious For Preparation For Flexible Sigmoidoscopy. Clin Transl Gastroenterol (2016) 0.75
Surveillance of colonic polyps: Are we getting it right? World J Gastroenterol (2016) 0.75
Prevalence and risk factors for post-investigation colorectal cancer ("interval cancer") after computed tomographic colonography: protocol for a systematic review. Syst Rev (2017) 0.75
Should Screening Colonoscopy Be Offered From Age 50? Dtsch Arztebl Int (2017) 0.75
Accounting for misclassification in electronic health records-derived exposures using generalized linear finite mixture models. Health Serv Outcomes Res Methodol (2016) 0.75
International variation in the prevalence of preclinical colorectal cancer: Implications for predictive values of noninvasive screening tests and potential target populations for screening. Int J Cancer (2017) 0.75
Association Between Colorectal Cancer Mortality and Gradient Fecal Hemoglobin Concentration in Colonoscopy Noncompliers. J Natl Cancer Inst (2017) 0.75
Colorectal cancer, screening and primary care: A mini literature review. World J Gastroenterol (2017) 0.75
Diagnostic performance of flexible sigmoidoscopy combined with fecal immunochemical test in colorectal cancer screening: meta-analysis and modeling. Eur J Epidemiol (2017) 0.75
Family Physicians' Knowledge, Attitudes, and Practices Toward Colorectal Cancer Screening. J Cancer Educ (2017) 0.75
Colorectal cancer screening: An updated review of the available options. World J Gastroenterol (2017) 0.75
Meta-analysis in clinical trials. Control Clin Trials (1986) 144.91
Bias in meta-analysis detected by a simple, graphical test. BMJ (1997) 122.24
Quantifying heterogeneity in a meta-analysis. Stat Med (2002) 83.16
Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA (2000) 55.37
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ (2009) 22.18
Prevention of colorectal cancer by colonoscopic polypectomy. The National Polyp Study Workgroup. N Engl J Med (1993) 21.18
Association of colonoscopy and death from colorectal cancer. Ann Intern Med (2008) 15.51
Once-only flexible sigmoidoscopy screening in prevention of colorectal cancer: a multicentre randomised controlled trial. Lancet (2010) 15.50
Colorectal cancer screening and surveillance: clinical guidelines and rationale-Update based on new evidence. Gastroenterology (2003) 14.67
Colorectal-cancer incidence and mortality with screening flexible sigmoidoscopy. N Engl J Med (2012) 11.48
A case-control study of screening sigmoidoscopy and mortality from colorectal cancer. N Engl J Med (1992) 10.70
The results of direct and indirect treatment comparisons in meta-analysis of randomized controlled trials. J Clin Epidemiol (1997) 9.01
Long-term colorectal-cancer incidence and mortality after lower endoscopy. N Engl J Med (2013) 7.72
Protection from colorectal cancer after colonoscopy: a population-based, case-control study. Ann Intern Med (2011) 6.50
Risk of developing colorectal cancer following a negative colonoscopy examination: evidence for a 10-year interval between colonoscopies. JAMA (2006) 6.26
Screening sigmoidoscopy and colorectal cancer mortality. J Natl Cancer Inst (1992) 6.18
Risk of colorectal cancer seven years after flexible sigmoidoscopy screening: randomised controlled trial. BMJ (2009) 5.69
Protection by endoscopy against death from colorectal cancer. A case-control study among veterans. Arch Intern Med (1995) 5.59
Are there two sides to colorectal cancer? Int J Cancer (2002) 5.18
Rates of new or missed colorectal cancers after colonoscopy and their risk factors: a population-based analysis. Gastroenterology (2007) 4.37
Colorectal cancer prevention 2000: screening recommendations of the American College of Gastroenterology. American College of Gastroenterology. Am J Gastroenterol (2000) 4.17
Complications following colonoscopy with anesthesia assistance: a population-based analysis. JAMA Intern Med (2013) 4.07
Effect of screening colonoscopy on colorectal cancer incidence and mortality. Clin Gastroenterol Hepatol (2009) 3.96
The reduction in colorectal cancer mortality after colonoscopy varies by site of the cancer. Gastroenterology (2010) 3.87
Once-only sigmoidoscopy in colorectal cancer screening: follow-up findings of the Italian Randomized Controlled Trial--SCORE. J Natl Cancer Inst (2011) 3.75
Prevention of colorectal cancer by flexible endoscopy and polypectomy. A case-control study of 32,702 veterans. Ann Intern Med (1995) 3.54
Reduced risk of colorectal cancer up to 10 years after screening, surveillance, or diagnostic colonoscopy. Gastroenterology (2013) 3.25
Population-based surveillance by colonoscopy: effect on the incidence of colorectal cancer. Telemark Polyp Study I. Scand J Gastroenterol (1999) 2.89
Association between colonoscopy and colorectal cancer mortality in a US cohort according to site of cancer and colonoscopist specialty. J Clin Oncol (2012) 2.77
Association between colonoscopy rates and colorectal cancer mortality. Am J Gastroenterol (2010) 2.56
American Cancer Society Guidelines for the Early Detection of Cancer, 2005. CA Cancer J Clin (2005) 2.35
Patterns of colorectal cancer test use, including CT colonography, in the 2010 National Health Interview Survey. Cancer Epidemiol Biomarkers Prev (2012) 2.31
Long-term efficacy of sigmoidoscopy in the reduction of colorectal cancer incidence. J Natl Cancer Inst (2003) 2.29
Systematic review and meta-analysis of the evidence for flexible sigmoidoscopy as a screening method for the prevention of colorectal cancer. Br J Surg (2012) 2.25
CIMP status of interval colon cancers: another piece to the puzzle. Am J Gastroenterol (2009) 2.17
Colonoscopic miss rates for right-sided colon cancer: a population-based analysis. Gastroenterology (2004) 2.17
Screening colonoscopy and risk for incident late-stage colorectal cancer diagnosis in average-risk adults: a nested case-control study. Ann Intern Med (2013) 2.15
[S3-Guidelines Conference "Colorectal Carcinoma" 2004]. Z Gastroenterol (2004) 2.03
Utilization of lower gastrointestinal endoscopy and fecal occult blood test in 11 European countries: evidence from the Survey of Health, Aging and Retirement in Europe (SHARE). Endoscopy (2010) 1.68
Effect of colonoscopy on colorectal cancer incidence and mortality: an instrumental variable analysis. Gastrointest Endosc (2012) 1.67
Differences between right- and left-sided colon cancer in patient characteristics, cancer morphology and histology. J Gastroenterol Hepatol (2007) 1.45
The NordICC Study: rationale and design of a randomized trial on colonoscopy screening for colorectal cancer. Endoscopy (2012) 1.44
The prevention of invasive cancer of the rectum. Cancer (1978) 1.43
Effect of flexible sigmoidoscopy-based screening on incidence and mortality of colorectal cancer: a systematic review and meta-analysis of randomized controlled trials. PLoS Med (2012) 1.38
Trends in colorectal cancer incidence rates in the United States by tumor location and stage, 1992-2008. Cancer Epidemiol Biomarkers Prev (2012) 1.36
Colonoscopy screening markedly reduces the occurrence of colon carcinomas and carcinoma-related death: a closed cohort study. Gastrointest Endosc (2012) 1.24
Potential for colorectal cancer prevention of sigmoidoscopy versus colonoscopy: population-based case control study. Cancer Epidemiol Biomarkers Prev (2007) 1.16
Comparative effectiveness and cost-effectiveness of screening colonoscopy vs. sigmoidoscopy and alternative strategies. Am J Gastroenterol (2012) 1.16
Colon cancer screening, lifestyle, and risk of colon cancer. Cancer Causes Control (2000) 1.14
Screening endoscopy and risk of colorectal cancer in United States men. Cancer Causes Control (1998) 1.10
Exposure to colorectal examinations before a colorectal cancer diagnosis: a case-control study. Eur J Gastroenterol Hepatol (2010) 1.06
Long-lasting reduction of risk of colorectal cancer following screening endoscopy. Br J Cancer (2001) 1.05
Colonoscopy and fecal occult blood test use in Germany: results from a large insurance-based cohort. Endoscopy (2011) 1.04
Colorectal screening is associated with reduced colorectal cancer risk: a case-control study within the population-based Ontario Familial Colorectal Cancer Registry. Cancer Causes Control (2005) 1.03
Polypectomy of adenomas in the prevention of colorectal cancer: 10 years' follow-up of the Telemark Polyp Study I. A prospective, controlled population study. Scand J Gastroenterol (1996) 1.02
Subsite-specific colorectal cancer risk in the colorectal endoscopy era. Gastrointest Endosc (2012) 0.98
A 9-year follow-up study of participants and nonparticipants in sigmoidoscopy screening: importance of self-selection. Cancer Epidemiol Biomarkers Prev (2008) 0.96
Population-based prevalence estimates of history of colonoscopy or sigmoidoscopy: review and analysis of recent trends. Gastrointest Endosc (2009) 0.92
Outpatient colonoscopy complications in the CDC's Colorectal Cancer Screening Demonstration Program: a prospective analysis. Cancer (2013) 0.92
Adverse events requiring hospitalization within 30 days after outpatient screening and nonscreening colonoscopies. Gastrointest Endosc (2013) 0.88
Risk of proximal and distal colorectal cancer following flexible sigmoidoscopy: a population-based cohort study. Am J Gastroenterol (2008) 0.87
In the era of widespread endoscopy use, randomized trials may strongly underestimate the effects of colorectal cancer screening. J Clin Epidemiol (2013) 0.85
Colorectal cancer screening: a community case-control study of proctosigmoidoscopy, barium enema radiography, and fecal occult blood test efficacy. Mayo Clin Proc (1999) 0.83
Risk of colorectal cancer after colonoscopy compared with flexible sigmoidoscopy or no lower endoscopy among older patients in the United States, 1998-2005. Mayo Clin Proc (2013) 0.81
Colorectal cancer incidence is low in patients following a colonoscopy. Dig Liver Dis (2011) 0.80
Case-control studies of the efficacy of cancer screening: overcoming bias from nonrandom patterns of screening. Epidemiology (2004) 0.77